Cutaneous true histiocytic malignancy: true histiocytic lymphoma.
True histiocytic malignancies (THM) are controversial disorders that are being re-evaluated with modern cellular and molecular biology techniques. True histiocytic lymphoma (THL) is a low-incidence, poor-prognosis THM. It mainly affects the skin, gastrointestinal tract, and bone tissues. Occasionally, skin lesions are the presenting clinical features. A patient with initially cutaneous THL is described. This and other reported cases confirm that THM are a nosologic entity by themselves.
Chaín
Myriam
M
Dermatology Division, Hospital de Clinicas, University of Buenos Aires School of Medicine, Córdoba 2351, Buenos Aires 1120, Argentina.
Dei-Cas
Ignacio
I
Carbia
Sergio
S
Xifra
Mariana
M
Wright
Dolores
D
Glorio
Roberto
R
Devés
Alberto
A
Woscoff
Alberto
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D015620:Histiocytic Disorders, Malignant / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D009336:Necrosis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology